Establishment, characterization and determination of cell surface sugar receptor (lectin) expression by neoglycoenzymes of a human myeloid marker-expressing B lymphoblastoid cell line

S. Gabius, S. S. Joshi, H. J. Gabius, J. G. Sharp

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Mediation of cellular interactions by protein(lectin)-carbohydrate recognition presupposes the expression of respective surface determinants. Due to the importance of cellular contacts between bone marrow stromal cells, recently shown to express cell surface lectins, and tumor or normal progenitor cells for biosignaling and marrow egress, quantitation of cell surface sugar receptor expression by a panel of chemically glycosylated enzymes (tetrameric E. coli β-galactosidase) for human leukemia/lymphoma cells was initiated. Cells of the new B lymphoblastoid line Croco II that are partially positive for the CD15-specific epitope expressed receptors for various sugar specificities on their surface, fulfilling an indispensable prerequisite for establishment of glycobiological interactions. Binding studies with increasing neoglycoenzyme concentrations up to saturation in four cases disclosed values for apparent affinity constants in the ranige of 25-200 nM with 0.25-3 x 105 bound probes per cell. The presence of receptors for constituents of carbohydrate chains of cellular glycoconjugates was also ascertained biochemically, namely for β-galactosides, o-mannosides, α-fucosides and N-acetylgalactosaminides. Expression of this property was modulated by changes in the culture conditions, as revealed by binding studies with cells, derived from growth in medium containing different serum concentrations. These findings indicate that cell surface sugar receptors of tumor cells warrant further attention with respect to recognitive interactions.

Original languageEnglish (US)
Pages (from-to)793-800
Number of pages8
JournalAnticancer Research
Volume11
Issue number2
StatePublished - Jan 1 1991

Fingerprint

Cell Surface Receptors
Lectins
Cell Line
Carbohydrates
Galactosidases
Mannosides
Galactosides
Glycoconjugates
Mesenchymal Stromal Cells
Epitopes
Lymphoma
Neoplasms
Leukemia
Stem Cells
Bone Marrow
Escherichia coli
Enzymes
Growth
Serum
Proteins

Keywords

  • bone marrow
  • cell line
  • lectin
  • leukemia
  • lymphoblast

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{df117b464c68400ab5df068fb612a694,
title = "Establishment, characterization and determination of cell surface sugar receptor (lectin) expression by neoglycoenzymes of a human myeloid marker-expressing B lymphoblastoid cell line",
abstract = "Mediation of cellular interactions by protein(lectin)-carbohydrate recognition presupposes the expression of respective surface determinants. Due to the importance of cellular contacts between bone marrow stromal cells, recently shown to express cell surface lectins, and tumor or normal progenitor cells for biosignaling and marrow egress, quantitation of cell surface sugar receptor expression by a panel of chemically glycosylated enzymes (tetrameric E. coli β-galactosidase) for human leukemia/lymphoma cells was initiated. Cells of the new B lymphoblastoid line Croco II that are partially positive for the CD15-specific epitope expressed receptors for various sugar specificities on their surface, fulfilling an indispensable prerequisite for establishment of glycobiological interactions. Binding studies with increasing neoglycoenzyme concentrations up to saturation in four cases disclosed values for apparent affinity constants in the ranige of 25-200 nM with 0.25-3 x 105 bound probes per cell. The presence of receptors for constituents of carbohydrate chains of cellular glycoconjugates was also ascertained biochemically, namely for β-galactosides, o-mannosides, α-fucosides and N-acetylgalactosaminides. Expression of this property was modulated by changes in the culture conditions, as revealed by binding studies with cells, derived from growth in medium containing different serum concentrations. These findings indicate that cell surface sugar receptors of tumor cells warrant further attention with respect to recognitive interactions.",
keywords = "bone marrow, cell line, lectin, leukemia, lymphoblast",
author = "S. Gabius and Joshi, {S. S.} and Gabius, {H. J.} and Sharp, {J. G.}",
year = "1991",
month = "1",
day = "1",
language = "English (US)",
volume = "11",
pages = "793--800",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - Establishment, characterization and determination of cell surface sugar receptor (lectin) expression by neoglycoenzymes of a human myeloid marker-expressing B lymphoblastoid cell line

AU - Gabius, S.

AU - Joshi, S. S.

AU - Gabius, H. J.

AU - Sharp, J. G.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Mediation of cellular interactions by protein(lectin)-carbohydrate recognition presupposes the expression of respective surface determinants. Due to the importance of cellular contacts between bone marrow stromal cells, recently shown to express cell surface lectins, and tumor or normal progenitor cells for biosignaling and marrow egress, quantitation of cell surface sugar receptor expression by a panel of chemically glycosylated enzymes (tetrameric E. coli β-galactosidase) for human leukemia/lymphoma cells was initiated. Cells of the new B lymphoblastoid line Croco II that are partially positive for the CD15-specific epitope expressed receptors for various sugar specificities on their surface, fulfilling an indispensable prerequisite for establishment of glycobiological interactions. Binding studies with increasing neoglycoenzyme concentrations up to saturation in four cases disclosed values for apparent affinity constants in the ranige of 25-200 nM with 0.25-3 x 105 bound probes per cell. The presence of receptors for constituents of carbohydrate chains of cellular glycoconjugates was also ascertained biochemically, namely for β-galactosides, o-mannosides, α-fucosides and N-acetylgalactosaminides. Expression of this property was modulated by changes in the culture conditions, as revealed by binding studies with cells, derived from growth in medium containing different serum concentrations. These findings indicate that cell surface sugar receptors of tumor cells warrant further attention with respect to recognitive interactions.

AB - Mediation of cellular interactions by protein(lectin)-carbohydrate recognition presupposes the expression of respective surface determinants. Due to the importance of cellular contacts between bone marrow stromal cells, recently shown to express cell surface lectins, and tumor or normal progenitor cells for biosignaling and marrow egress, quantitation of cell surface sugar receptor expression by a panel of chemically glycosylated enzymes (tetrameric E. coli β-galactosidase) for human leukemia/lymphoma cells was initiated. Cells of the new B lymphoblastoid line Croco II that are partially positive for the CD15-specific epitope expressed receptors for various sugar specificities on their surface, fulfilling an indispensable prerequisite for establishment of glycobiological interactions. Binding studies with increasing neoglycoenzyme concentrations up to saturation in four cases disclosed values for apparent affinity constants in the ranige of 25-200 nM with 0.25-3 x 105 bound probes per cell. The presence of receptors for constituents of carbohydrate chains of cellular glycoconjugates was also ascertained biochemically, namely for β-galactosides, o-mannosides, α-fucosides and N-acetylgalactosaminides. Expression of this property was modulated by changes in the culture conditions, as revealed by binding studies with cells, derived from growth in medium containing different serum concentrations. These findings indicate that cell surface sugar receptors of tumor cells warrant further attention with respect to recognitive interactions.

KW - bone marrow

KW - cell line

KW - lectin

KW - leukemia

KW - lymphoblast

UR - http://www.scopus.com/inward/record.url?scp=0025775627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025775627&partnerID=8YFLogxK

M3 - Article

C2 - 1712180

AN - SCOPUS:0025775627

VL - 11

SP - 793

EP - 800

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2

ER -